Institut Pasteur, Centre National de Référence de la Résistance aux Antibiotiques, Paris, France.
Antimicrob Agents Chemother. 2010 Jun;54(6):2728-31. doi: 10.1128/AAC.01557-09. Epub 2010 Apr 12.
Susceptibility to antibiotics of 4,816 clinical L. monocytogenes strains isolated since 1926 was studied, and the temporal evolution of susceptibility to antibiotics was analyzed through several decades. The mechanisms of resistance in each resistant strain were studied. The prevalence of resistant strains was estimated at 1.27% among isolates from humans. Resistance to tetracyclines+ and fluoroquinolones was more common and has recently emerged. Although acquired resistance in clinical L. monocytogenes did not implicate clinically relevant antibiotics, the possibility of resistance gene transfers, the description of the first clinical isolate with high-level resistance to trimethoprim, and the recent increase in penicillin MICs up to 2 microg/ml reinforce the need for microbiological surveillance.
自 1926 年以来,我们研究了 4816 株临床分离单核细胞增生李斯特菌对各种抗生素的敏感性,分析了几十年来其对抗生素敏感性的变化趋势。我们对每一株耐药菌株的耐药机制进行了研究。在从人类分离的菌株中,耐药株的流行率估计为 1.27%。对四环素类+和氟喹诺酮类的耐药性更为常见,而且最近还出现了新的耐药性。尽管临床分离单核细胞增生李斯特菌的获得性耐药并不意味着涉及临床相关的抗生素,但耐药基因转移的可能性、首例高水平耐甲氧苄啶的临床分离株的描述以及最近青霉素 MIC 值增加到 2μg/ml,都强化了微生物学监测的必要性。